Troxacitabine

Troxacitabine (brand name Troxatyl) is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.

This pharmacology-related article is a stub. You can help Wikipedia by expanding it.